Mitochondrial fatty acid oxidation defects—remaining challenges
- 7 October 2008
- journal article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 31 (5), 643-657
- https://doi.org/10.1007/s10545-008-0990-y
Abstract
Mitochondrial fatty acid oxidation defects have been recognized since the early 1970s. The discovery rate has been rather constant, with 3–4 ‘new’ disorders identified every decade and with the most recent example, ACAD9 deficiency, reported in 2007. In this presentation we will focus on three of the ‘old’ defects: medium-chain acyl-CoA dehydrogenase (MCAD) deficiency, riboflavin responsive multiple acyl-CoA dehydrogenation (RR-MAD) deficiency, and short-chain acyl-CoA dehydrogenase (SCAD) deficiency. These disorders have been discussed in many publications and at countless conference presentations, and many questions relating to them have been answered. However, continuing clinical and pathophysiological research has raised many further questions, and new ideas and methodologies may be required to answer these. We will discuss these challenges. For MCAD deficiency the key question is why 80% of symptomatic patients are homozygous for the prevalent ACADM gene variation c.985A > G whereas this is found in only ∼50% of newborns with a positive screen. For RR-MAD deficiency, the challenge is to find the connection between variations in the ETFDH gene and the observed deficiency of a number of different mitochondrial dehydrogenases as well as deficiency of FAD and coenzyme Q10. With SCAD deficiency, the challenge is to elucidate whether ACADS gene variations are disease-associated, especially when combined with other genetic/cellular/environmental factors, which may act synergistically.Keywords
This publication has 82 references indexed in Scilit:
- Splicing in disease: disruption of the splicing code and the decoding machineryNature Reviews Genetics, 2007
- A New Genetic Disorder in Mitochondrial Fatty Acid β-Oxidation: ACAD9 DeficiencyAmerican Journal of Human Genetics, 2007
- Seemingly Neutral Polymorphic Variants May Confer Immunity to Splicing-Inactivating Mutations: A Synonymous SNP in Exon 5 of MCAD Protects from Deleterious Mutations in a Flanking Exonic Splicing EnhancerAmerican Journal of Human Genetics, 2007
- Structure of electron transfer flavoprotein-ubiquinone oxidoreductase and electron transfer to the mitochondrial ubiquinone poolProceedings of the National Academy of Sciences, 2006
- Protein misfolding disorders: Pathogenesis and interventionJournal of Inherited Metabolic Disease, 2006
- Newborn screening for medium‐chain acyl‐CoA dehydrogenase deficiency: A global perspectiveJournal of Inherited Metabolic Disease, 2005
- Molecular basis of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: identification of the major disease-causing mutation in the α-subunit of the mitochondrial trifunctional proteinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Medium–chain acyl-coenzyme A dehydrogenase deficiency: Clinical course in 120 affected childrenThe Journal of Pediatrics, 1994
- Fasting hypoglycemia resulting from hepatic carnitine palmitoyl transferase deficiencyThe Journal of Pediatrics, 1981
- Muscle Carnitine Palmityltransferase Deficiency and MyoglobinuriaScience, 1973